The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Much at Stake for Rheumatology in Lame Duck Session of Congress

Much at Stake for Rheumatology in Lame Duck Session of Congress

December 1, 2012 • By Staff

  • Tweet
  • Email
Print-Friendly Version / Save PDF

With the 2012 elections behind them, the current Congress still has major issues to tackle before the end of the year and the beginning of the 113th Congress in January. While one key issue—funding the government—was handled by a six-month continuing resolution back in September that ensures the federal government will remain open at least through March 2013, several key items remain unresolved.

You Might Also Like
  • Contact Congress Today about Medicare Reimbursement
  • Congress Can Begin Work to Advance Rheumatology Before New Year
  • ACR Aims to Keep Rheumatology on Congressional Radar in 2014
Explore This Issue
December 2012
Also By This Author
  • Bridge the Gap Between Goal and Attainment

What is at stake for rheumatology as year closes?

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Unless the current Congress takes action to prevent them, massive mandatory spending cuts, or sequestration, are scheduled to go into effect in January, along with a nearly 30% cut to Medicare physician reimbursement and the expiration of several tax provisions. The most threatening cuts scheduled to go into effect on January 1 are:

  • A 30% Sustainable Growth Rate (SGR) cut to physician reimbursement;
  • A 2% sequestration cut to physician reimbursement; and an
  • An 8% sequestration cut to NIH funding.

We cannot take for granted that the SGR cuts will again be averted at the last moment.

Sequestration cuts would directly affect rheumatologists who see Medicare patients with a 2% cut to reimbursements, on top of any SGR cut, and would also impose massive cuts to the budgets of agencies like the NIH. The agency has said that the scheduled 8% cuts would affect every area of its programs, including rheumatology-related research.

Additionally, while a small number compared to the cost of continuing expiring tax policies and preventing other cuts, the cost to postpone drastic SGR cuts to Medicare physician reimbursement is $11 billion. Lawmakers have heard from ACR members this year about the critical need to prevent these cuts, and they must continue to hear from you that preventing these cuts is a paramount priority, so that patients’ access to the specialty care they depend on is not threatened. We cannot take for granted that the SGR cuts will again be averted at the last moment. If you haven’t gotten a message to your lawmakers about preventing these cuts, do so now by using the ACR’s Legislative Action Center at www.rheumatology.org/advocacy.

After the cuts are prevented, the ACR will continue to work with lawmakers and other medical societies for a permanent repeal and replacement of the SGR formula. We will continue to push for physician payment reform that takes into account the particular needs of the rheumatology subspecialty. When the time comes to finalize details of a long-term reform plan, the ACR and its members will be well positioned to influence the plan.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Take Action!

Send a message to your member of Congress now! They need to hear from you about how these cuts would impact your practice and patients who need care. Use the ACR’s Legislative Action Center at www.rheumatology.org/advocacy or use the AMA grassroots hotline at (800) 833-6354 to connect with your representative in Washington, D.C.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Pages: 1 2 | Single Page

Filed Under: From the College, Legislation & Advocacy, Professional Topics Tagged With: AC&R, Advocacy, American College of Rheumatology, Congress, Legislation, Medicare, physician reimbursement, rheumatologist, SGRIssue: December 2012

You Might Also Like:
  • Contact Congress Today about Medicare Reimbursement
  • Congress Can Begin Work to Advance Rheumatology Before New Year
  • ACR Aims to Keep Rheumatology on Congressional Radar in 2014
  • What’s in Store for Rheumatology in the 113th Congress?

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.